TP53 and posterior cortical atrophy: From a molecular pathophysiological standpoint, PTEN deficiency is the cornerstone for understanding how PCa cells escape normal growth restraints, as patients with PTEN-deficient tumors often exhibit more aggressive histopathological features—although co-mutations, such as those involving TP53, can sometimes overshadow the effect of loss of PTEN [61].